AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Celyad Oncology S.A.

$0.28 +$0.13 (+86.67%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.28
Day Range
$0.2$0.32
Year Range
$0.15$0.41
Market Cap
12.53M
AVG Volume
1
Trailing/Forward PE
12.62/-
PEG ratio
0.09
Dividend Yield
-
Next Earnings Date
2026-09-23
Primary Exchange
Other OTCUS
Revenue (EUR)
050K100K150K200K21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF Revenue (EUR) by quarter
PeriodRevenue (EUR)
25 Q47K
25 Q214K
24 Q4172K
24 Q214K
23 Q458K
23 Q244K
22 Q40
22 Q20
21 Q40
21 Q20
Net Income (EUR)
-30M-20M-10M010M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF Net Income (EUR) by quarter
PeriodNet Income (EUR)
25 Q44.5M
25 Q2-3.67M
24 Q4-2.78M
24 Q2-3.04M
23 Q4-4.71M
23 Q2-3.74M
22 Q4-26.88M
22 Q2-6.48M
21 Q4-4.27M
21 Q2-6.15M
Operating Income (EUR)
-30M-20M-10M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF Operating Income (EUR) by quarter
PeriodOperating Income (EUR)
25 Q4-3.43M
25 Q2-3.75M
24 Q4-2.77M
24 Q2-3.08M
23 Q4-4.71M
23 Q2-5.82M
22 Q4-26.78M
22 Q2-6.53M
21 Q4-4.07M
21 Q2-6.1M
EBITDA (EUR)
-30M-20M-10M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF EBITDA (EUR) by quarter
PeriodEBITDA (EUR)
25 Q4-3.43M
25 Q2-3.43M
24 Q4-2.56M
24 Q2-2.79M
23 Q4-4.47M
23 Q2-4.42M
22 Q4-26.41M
22 Q2-6.31M
21 Q4-3.53M
21 Q2-6.05M
Cash Flows (EUR)
-20M-15M-10M-5M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF Cash Flows (EUR) by quarter
PeriodCash Flows (EUR)
25 Q4-3.62M
25 Q2-3.86M
24 Q4-2.85M
24 Q2-2.83M
23 Q4-7.45M
23 Q2-8.68M
22 Q4-11.72M
22 Q2-16.41M
21 Q4-14.63M
21 Q2-12.41M
EPS (EUR)
-1.5-1-0.500.521 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF EPS (EUR) by quarter
PeriodEPS (EUR)
25 Q40.11
25 Q2-0.09
24 Q4-0.07
24 Q2-0.12
23 Q4-0.16
23 Q2-0.17
22 Q4-1.19
22 Q2-0.34
21 Q4-0.29
21 Q2-0.42
Expenses (EUR)
05M10M15MR&DSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF Expenses (EUR) by quarter
PeriodExpenses (EUR)
25 Q43.44M
25 Q23.55M
24 Q43.35M
24 Q23.27M
23 Q45.7M
23 Q25.76M
22 Q412.1M
22 Q29.05M
21 Q48.18M
21 Q27.88M
Cash & Debt (EUR)
-10M010M20M30M40MCashLong Term DebtShort Term Debt20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q225 Q225 Q4
CLYYF Cash & Debt (EUR) by quarter
PeriodCash & Debt (EUR)
25 Q41.71M
25 Q2790K
24 Q26.23M
23 Q47M
23 Q24.98M
22 Q412.45M
22 Q214.38M
21 Q430.02M
21 Q212.02M
20 Q417.23M
Debt ratios
-0.500.511.520 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q225 Q225 Q4
CLYYF Debt ratios by quarter
PeriodDebt ratios
25 Q40.14
25 Q2-0
24 Q20.14
23 Q40.15
23 Q20.11
22 Q4-0.11
22 Q21.2
21 Q41.38
21 Q20.3
20 Q40.34
Margins
-10000%0%10000%20000%30000%40000%18 Q218 Q419 Q420 Q223 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF Margins by quarter
PeriodMargins
25 Q430416.98%
25 Q2-1414.29%
24 Q498.26%
24 Q235.71%
23 Q456.9%
23 Q2-902.27%
20 Q2100%
19 Q4100%
18 Q4100%
18 Q2100%
Return on Capital
-400%-200%0%200%400%20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q225 Q225 Q4
CLYYF Return on Capital by quarter
PeriodReturn on Capital
25 Q4184.93%
25 Q2118.51%
24 Q2-93.23%
23 Q4-74.68%
23 Q2-367.03%
22 Q4218.28%
22 Q2-21.15%
21 Q4-9.79%
21 Q2-24.75%
20 Q415.56%
Shares Outstanding
020M40M60M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CLYYF Shares Outstanding by quarter
PeriodShares Outstanding
25 Q441.43M
25 Q241.43M
24 Q441.43M
24 Q225.72M
23 Q428.85M
23 Q222.59M
22 Q422.59M
22 Q219.1M
21 Q414.77M
21 Q214.77M
Book Value Per Share (EUR)
-1012320 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q225 Q225 Q4
CLYYF Book Value Per Share (EUR) by quarter
PeriodBook Value Per Share (EUR)
25 Q40.06
25 Q2-0.07
24 Q20.13
23 Q40.22
23 Q20.05
22 Q4-0.55
22 Q21.6
21 Q42.95
21 Q21.68
20 Q42.22
Total Assets (EUR)
020M40M60M80M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q225 Q225 Q4
CLYYF Total Assets (EUR) by quarter
PeriodTotal Assets (EUR)
25 Q44.3M
25 Q25.7M
24 Q212.85M
23 Q416.28M
23 Q212.18M
22 Q419.72M
22 Q263.14M
21 Q479.94M
21 Q262.69M
20 Q466.08M
Employee Count
05010015020152016201720182019202020212022
CLYYF Employee Count by quarter
PeriodEmployee Count
202228
202188
202092
2019101
201890
201770
201678
201582
Free Cash Flow Yield
-800%-600%-400%-200%0%med -181.06%Sep 24Jan 25Jul 25Oct 25Feb 26May 26Sep 26
CLYYF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-131.95%
Sep 26-131.84%
Aug 26-131.47%
Aug 26-132.53%
Aug 26-131.27%
Aug 26-131.17%
Jul 26-183.17%
Jul 26-180.67%
Jul 26-181.74%
Jul 26-181.39%
Jul 26-145.35%
Jun 26-144.7%
Jun 26-145.7%
Jun 26-147.04%
Jun 26-146.43%
May 26-148.14%
May 26-147.45%
May 26-147.8%
May 26-149.8%
May 26-148.97%
Apr 26-148.99%
Apr 26-106.81%
Apr 26-106.46%
Apr 26-104.8%
Mar 26-134.89%
Mar 26-135.61%
Mar 26-134.06%
Mar 26-136.17%
Feb 26-323.34%
Feb 26-322.19%
Feb 26-324.6%
Feb 26-323.11%
Jan 26-324.07%
Jan 26-323.49%
Jan 26-317.22%
Jan 26-318.22%
Jan 26-320.53%
Dec 25-321.93%
Dec 25-266.83%
Dec 25-267.55%
Dec 25-265.31%
Nov 25-264.29%
Nov 25-236.14%
Nov 25-238.36%
Nov 25-237.17%
Oct 25-237.48%
Oct 25-238.53%
Oct 25-116.58%
Oct 25-116.33%
Oct 25-117.5%
Sep 25-150.3%
Sep 25-150.85%
Sep 25-150.65%
Sep 25-150.55%
Aug 25-150.12%
Aug 25-150.6%
Aug 25-150.37%
Aug 25-115.67%
Aug 25-115.13%
Jul 25-123.66%
Jul 25-122.43%
Jul 25-123.11%
Jul 25-123.84%
Jun 25-123.4%
Jun 25-121.38%
Jun 25-121.68%
Jun 25-120.01%
May 25-119.55%
May 25-92.11%
Feb 25-191.76%
Feb 25-184.1%
Feb 25-181.23%
Jan 25-181.76%
Jan 25-184.12%
Jan 25-180.21%
Jan 25-179.78%
Jan 25-180.9%
Dec 24-507.63%
Dec 24-507.89%
Dec 24-511.52%
Dec 24-514.6%
Nov 24-515.15%
Nov 24-507.47%
Nov 24-513.36%
Nov 24-522%
Nov 24-528%
Oct 24-525.83%
Sep 24-700.32%
Sep 24-699.22%
Sep 24-693.72%
Sep 24-680.53%
Aug 24-678.42%
Aug 24-687%
Aug 24-676.93%
Aug 24-670.13%
Aug 24-669.91%
Jul 24-666.34%
Jul 24-664.68%
May 24-524.69%
Apr 24-460.62%
Price to Sales
050100150med 50.34Sep 24Jan 25Jul 25Oct 25Feb 26May 26Sep 26
CLYYF Price to Sales by quarter
PeriodPrice to Sales
Sep 2648.19
Sep 2648.23
Aug 2648.36
Aug 2647.98
Aug 2648.43
Aug 2648.47
Jul 2634.71
Jul 2635.19
Jul 2634.98
Jul 2635.05
Jul 2643.75
Jun 2643.94
Jun 2643.64
Jun 2643.24
Jun 2643.42
May 2642.92
May 2643.12
May 2643.02
May 2642.44
May 2642.68
Apr 2642.68
Apr 2659.53
Apr 2659.72
Apr 2660.67
Mar 2648.82
Mar 2648.56
Mar 2649.13
Mar 2648.36
Feb 2620.37
Feb 2620.44
Feb 2620.29
Feb 2620.38
Jan 2620.32
Jan 2620.36
Jan 2620.76
Jan 2620.7
Jan 2620.55
Dec 2520.46
Dec 2524.68
Dec 2524.61
Dec 2524.82
Nov 2524.92
Nov 2527.89
Nov 2527.63
Nov 2527.77
Oct 2527.73
Oct 2527.61
Oct 2556.49
Oct 2556.61
Oct 2556.05
Sep 2550.4
Sep 2550.21
Sep 2550.28
Sep 2550.31
Aug 2550.46
Aug 2550.3
Aug 2550.37
Aug 2565.49
Aug 2565.79
Jul 2561.26
Jul 2561.87
Jul 2561.53
Jul 2561.17
Jun 2561.38
Jun 2562.4
Jun 2562.25
Jun 2563.11
May 2563.36
May 2582.24
Feb 25137.95
Feb 25143.68
Feb 25145.96
Jan 25145.54
Jan 25143.67
Jan 25146.79
Jan 25147.14
Jan 25146.23
Dec 2452.11
Dec 2452.08
Dec 2451.71
Dec 2451.4
Nov 2451.35
Nov 2452.13
Nov 2451.53
Nov 2450.68
Nov 2450.1
Oct 2450.31
Sep 2461.97
Sep 2462.07
Sep 2462.56
Sep 2463.77
Aug 2463.97
Aug 2463.17
Aug 2464.11
Aug 2464.76
Aug 2464.79
Jul 2465.13
Jul 2465.29
May 2482.72
Apr 2494.22
Price to Book
05101520med 3.64Dec 22Mar 24Sep 24Dec 24Apr 26Jun 26Sep 26
CLYYF Price to Book by quarter
PeriodPrice to Book
Sep 264.1
Sep 264.1
Aug 264.11
Aug 264.08
Aug 264.12
Aug 264.12
Jul 262.95
Jul 262.99
Jul 262.97
Jul 262.98
Jul 263.72
Jun 263.74
Jun 263.71
Jun 263.68
Jun 263.69
May 263.65
May 263.67
May 263.66
May 263.61
May 263.63
Apr 263.63
Apr 265.06
Apr 265.08
Apr 265.16
Feb 254.9
Feb 255.1
Feb 255.19
Jan 255.17
Jan 255.1
Jan 255.22
Jan 255.23
Jan 255.2
Dec 241.85
Dec 241.85
Dec 241.84
Dec 241.83
Nov 241.82
Nov 241.85
Nov 241.83
Nov 241.8
Nov 241.78
Oct 241.79
Sep 241
Sep 241
Sep 241.01
Sep 241.03
Aug 241.04
Aug 241.02
Aug 241.04
Aug 241.05
Aug 241.05
Jul 241.05
Jul 241.06
May 241.34
Apr 241.52
Mar 248.15
Feb 248.48
Feb 248.51
Feb 248.71
Feb 248.67
Jan 2410.2
Jan 248.78
Dec 238.67
Dec 238.07
Nov 2311.07
Oct 2315.4
Dec 220.15
Dec 212.44
Nov 212.04
Oct 212.41
Oct 203.56
Jan 203.22
Celyad Oncology S.A.
CLYYF
Stockpicker

Video analysis: CLYYF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.